Kazia Therapeutics (KZIA) has released an update.
Kazia Therapeutics plans to modify the ratio of its American Depositary Shares (ADS) to improve its trading price on Nasdaq, with the new ratio set to take effect on October 28, 2024. This change aims to help the company meet Nasdaq’s minimum bid price requirement, but there is no guarantee it will succeed. The adjustment will not affect the number of underlying Ordinary Shares, and the company’s stock will continue to trade under the ticker symbol ‘KZIA.’
For further insights into KZIA stock, check out TipRanks’ Stock Analysis page.
